Influenza Virus Vaccine (H1N1) Market Report

Global and Region Influenza Virus Vaccine (H1N1) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：230
  • REPORT CODE：GMM966880
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Influenza Virus Vaccine (H1N1) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Influenza Virus Vaccine (H1N1)market, defines the market attractiveness level of Influenza Virus Vaccine (H1N1) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Influenza Virus Vaccine (H1N1) industry, describes the types of Influenza Virus Vaccine (H1N1) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Influenza Virus Vaccine (H1N1) market and the development prospects and opportunities of Influenza Virus Vaccine (H1N1) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Influenza Virus Vaccine (H1N1) market in Chapter 13.

    By Player:

    • Dalian Yalifeng Bio-Pharmaceutical

    • Zhejiang Tianyuan Bio-Pharmaceutical

    • NVS(Novartis)

    • Medimmune

    • GSK

    • Jiangsu Yanshen Bio-Technology

    • Sanofi Pasteur

    • Sinopharm

    • CSL

    • Beijing Tiantan Bio-Products

    • Changchun Changsheng Bio-Technology

    • Hualan Bio-Vaccine

    • Baxter

    • Beijing Kexing Bio-Vaccine

    By Type:

    • Intramuscular Vaccine

    • Nasal Spray Vaccine

    By End-User:

    • 3 To 10 Years Old

    • 10 To 18 Years Old

    • Above 18 Years Old

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Influenza Virus Vaccine (H1N1) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Influenza Virus Vaccine (H1N1) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Influenza Virus Vaccine (H1N1) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Influenza Virus Vaccine (H1N1) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Influenza Virus Vaccine (H1N1) Market Analysis and Outlook to 2022

    • 7.1 Global Influenza Virus Vaccine (H1N1) Consumption (2017-2022)

    • 7.2 United States Influenza Virus Vaccine (H1N1) Consumption (2017-2022)

    • 7.3 Europe Influenza Virus Vaccine (H1N1) Consumption (2017-2022)

    • 7.4 China Influenza Virus Vaccine (H1N1) Consumption (2017-2022)

    • 7.5 Japan Influenza Virus Vaccine (H1N1) Consumption (2017-2022)

    • 7.6 India Influenza Virus Vaccine (H1N1) Consumption (2017-2022)

    • 7.7 South Korea Influenza Virus Vaccine (H1N1) Consumption (2017-2022)

    8 Region and Country-wise Influenza Virus Vaccine (H1N1) Market Analysis and Outlook to 2028

    • 8.1 Global Influenza Virus Vaccine (H1N1) Consumption Forecast (2022-2028)

    • 8.2 United States Influenza Virus Vaccine (H1N1) Consumption Forecast (2022-2028)

    • 8.3 Europe Influenza Virus Vaccine (H1N1) Consumption Forecast (2022-2028)

    • 8.4 China Influenza Virus Vaccine (H1N1) Consumption Forecast (2022-2028)

    • 8.5 Japan Influenza Virus Vaccine (H1N1) Consumption Forecast (2022-2028)

    • 8.6 India Influenza Virus Vaccine (H1N1) Consumption Forecast (2022-2028)

    • 8.7 South Korea Influenza Virus Vaccine (H1N1) Consumption Forecast (2022-2028)

    9 Global Influenza Virus Vaccine (H1N1) Market Outlook by Types and Applications to 2022

    • 9.1 Global Influenza Virus Vaccine (H1N1) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Intramuscular Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Nasal Spray Vaccine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Influenza Virus Vaccine (H1N1) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global 3 To 10 Years Old Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global 10 To 18 Years Old Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Above 18 Years Old Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Influenza Virus Vaccine (H1N1) Market Outlook by Types and Applications to 2028

    • 10.1 Global Influenza Virus Vaccine (H1N1) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Intramuscular Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Nasal Spray Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Influenza Virus Vaccine (H1N1) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global 3 To 10 Years Old Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global 10 To 18 Years Old Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Above 18 Years Old Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Influenza Virus Vaccine (H1N1) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Influenza Virus Vaccine (H1N1) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Influenza Virus Vaccine (H1N1) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Influenza Virus Vaccine (H1N1) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Influenza Virus Vaccine (H1N1) Market Competitive Analysis

    • 14.1 Dalian Yalifeng Bio-Pharmaceutical

      • 14.1.1 Dalian Yalifeng Bio-Pharmaceutical Company Details

      • 14.1.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product and Service

    • 14.2 Zhejiang Tianyuan Bio-Pharmaceutical

      • 14.2.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Details

      • 14.2.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product and Service

    • 14.3 NVS(Novartis)

      • 14.3.1 NVS(Novartis) Company Details

      • 14.3.2 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product and Service

    • 14.4 Medimmune

      • 14.4.1 Medimmune Company Details

      • 14.4.2 Medimmune Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Medimmune Influenza Virus Vaccine (H1N1) Product and Service

    • 14.5 GSK

      • 14.5.1 GSK Company Details

      • 14.5.2 GSK Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GSK Influenza Virus Vaccine (H1N1) Product and Service

    • 14.6 Jiangsu Yanshen Bio-Technology

      • 14.6.1 Jiangsu Yanshen Bio-Technology Company Details

      • 14.6.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product and Service

    • 14.7 Sanofi Pasteur

      • 14.7.1 Sanofi Pasteur Company Details

      • 14.7.2 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product and Service

    • 14.8 Sinopharm

      • 14.8.1 Sinopharm Company Details

      • 14.8.2 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sinopharm Influenza Virus Vaccine (H1N1) Product and Service

    • 14.9 CSL

      • 14.9.1 CSL Company Details

      • 14.9.2 CSL Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 CSL Influenza Virus Vaccine (H1N1) Product and Service

    • 14.10 Beijing Tiantan Bio-Products

      • 14.10.1 Beijing Tiantan Bio-Products Company Details

      • 14.10.2 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product and Service

    • 14.11 Changchun Changsheng Bio-Technology

      • 14.11.1 Changchun Changsheng Bio-Technology Company Details

      • 14.11.2 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product and Service

    • 14.12 Hualan Bio-Vaccine

      • 14.12.1 Hualan Bio-Vaccine Company Details

      • 14.12.2 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product and Service

    • 14.13 Baxter

      • 14.13.1 Baxter Company Details

      • 14.13.2 Baxter Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Baxter Influenza Virus Vaccine (H1N1) Product and Service

    • 14.14 Beijing Kexing Bio-Vaccine

      • 14.14.1 Beijing Kexing Bio-Vaccine Company Details

      • 14.14.2 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Influenza Virus Vaccine (H1N1)

    • Figure Influenza Virus Vaccine (H1N1) Picture

    • Table Global Influenza Virus Vaccine (H1N1) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Virus Vaccine (H1N1) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Virus Vaccine (H1N1) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Influenza Virus Vaccine (H1N1) Consumption by Country (2017-2022)

    • Figure United States Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2017-2022)

    • Table Europe Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2017-2022)

    • Figure China Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2017-2022)

    • Figure Japan Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2017-2022)

    • Figure India Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Influenza Virus Vaccine (H1N1) Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Virus Vaccine (H1N1) Consumption Forecast by Country (2022-2028)

    • Figure United States Influenza Virus Vaccine (H1N1) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Influenza Virus Vaccine (H1N1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Influenza Virus Vaccine (H1N1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Influenza Virus Vaccine (H1N1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Influenza Virus Vaccine (H1N1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Influenza Virus Vaccine (H1N1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intramuscular Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Nasal Spray Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global 3 To 10 Years Old Consumption and Growth Rate (2017-2022)

    • Figure Global 10 To 18 Years Old Consumption and Growth Rate (2017-2022)

    • Figure Global Above 18 Years Old Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Intramuscular Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nasal Spray Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 3 To 10 Years Old Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 10 To 18 Years Old Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Above 18 Years Old Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Influenza Virus Vaccine (H1N1) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Influenza Virus Vaccine (H1N1) Export by Region (Top 5 Countries) (2017-2028)

    • Table Dalian Yalifeng Bio-Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product and Service

    • Table Zhejiang Tianyuan Bio-Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product and Service

    • Table NVS(Novartis) (Foundation Year, Company Profile and etc.)

    • Table NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table NVS(Novartis) Influenza Virus Vaccine (H1N1) Product and Service

    • Table Medimmune (Foundation Year, Company Profile and etc.)

    • Table Medimmune Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medimmune Influenza Virus Vaccine (H1N1) Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Influenza Virus Vaccine (H1N1) Product and Service

    • Table Jiangsu Yanshen Bio-Technology (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product and Service

    • Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product and Service

    • Table Sinopharm (Foundation Year, Company Profile and etc.)

    • Table Sinopharm Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sinopharm Influenza Virus Vaccine (H1N1) Product and Service

    • Table CSL (Foundation Year, Company Profile and etc.)

    • Table CSL Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Influenza Virus Vaccine (H1N1) Product and Service

    • Table Beijing Tiantan Bio-Products (Foundation Year, Company Profile and etc.)

    • Table Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product and Service

    • Table Changchun Changsheng Bio-Technology (Foundation Year, Company Profile and etc.)

    • Table Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product and Service

    • Table Hualan Bio-Vaccine (Foundation Year, Company Profile and etc.)

    • Table Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product and Service

    • Table Baxter (Foundation Year, Company Profile and etc.)

    • Table Baxter Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Influenza Virus Vaccine (H1N1) Product and Service

    • Table Beijing Kexing Bio-Vaccine (Foundation Year, Company Profile and etc.)

    • Table Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US